Cover Image
市場調查報告書

平滑肌肉瘤:全球臨床實驗檢討

Leiomyosarcoma Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 247626
出版日期 內容資訊 英文 96 Pages
訂單完成後即時交付
價格
Back to Top
平滑肌肉瘤:全球臨床實驗檢討 Leiomyosarcoma Global Clinical Trials Review, H1, 2014
出版日期: 2014年02月28日 內容資訊: 英文 96 Pages
簡介

本報告提供平滑肌肉瘤治療藥物的臨床實驗資料,彙整各國的趨勢,臨床實驗數,全球各臨床實驗中心的募集情況等資料,為您概述為以下內容。

目錄

簡介

  • 平滑肌肉瘤
  • 關於本報告

各地區的臨床試驗

  • 臨床試驗:各國
    • 亞太地區前五名國家
    • 歐洲的前五國
    • 北美前幾名國家
    • 中東及非洲的前幾名國家
    • 中南美的主要國家

G7各國的臨床試驗

G7各國的臨床試驗:各臨床實驗狀態

E7各國的臨床試驗

E7各國的臨床試驗:各臨床實驗狀態

Phase別的臨床試驗

  • 進行中的臨床實驗:Phase別

臨床試驗:各臨床實驗狀態

未完成的臨床實驗

每段時期的實驗人數

有力的贊助商

  • 主要參與臨床實驗的企業

潛力治療藥物

臨床試驗簡介

  • 臨床試驗概要:主要企業
    • Sarcoma Alliance for Research through Collaboration
    • Janssen Global Services, LLC
    • Eisai
    • 日本化藥.
    • Merck & Co., Inc.
    • Johnson & Johnson
    • Eli Lilly and Company
    • 第一三強
    • Cell Therapeutics, Inc.
    • ArQule, Inc.
  • 臨床試驗概要:最高級大學 / 研究機關 / 醫院
    • National Cancer Institute
    • Gynecologic Oncology Group
    • European Organization for Research and Treatment of Cancer
    • Memorial Sloan Kettering Cancer Center
    • The University of Texas M. D. Anderson Cancer Center
    • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
    • New York University School of Medicine
    • UNICANCER Group
    • Case Comprehensive Cancer Center

主要臨床實驗5件簡介

附錄

  • 簡稱
  • 定義
  • 調查方法
  • 二次調查
  • 關於GlobalData
  • 諮詢方式
  • 免責聲明
  • 資訊來源

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2018CTIDB

GlobalData's clinical trial report, "Leiomyosarcoma Global Clinical Trials Review, H1, 2014" provides data on the Leiomyosarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Leiomyosarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Leiomyosarcoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Leiomyosarcoma
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Leiomyosarcoma to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Leiomyosarcoma to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Leiomyosarcoma
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Leiomyosarcoma Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Sarcoma Alliance for Research through Collaboration
      • Clinical Trial Overview of Sarcoma Alliance for Research through Collaboration
      • Janssen Global Services, LLC
      • Clinical Trial Overview of Janssen Global Services, LLC
      • Eisai Co., Ltd.
      • Clinical Trial Overview of Eisai Co., Ltd.
      • Nippon Kayaku Co., Ltd.
      • Clinical Trial Overview of Nippon Kayaku Co., Ltd.
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • Daiichi Sankyo Company, Limited
      • Clinical Trial Overview of Daiichi Sankyo Company, Limited
      • Cell Therapeutics, Inc.
      • Clinical Trial Overview of Cell Therapeutics, Inc.
      • ArQule, Inc.
      • Clinical Trial Overview of ArQule, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Gynecologic Oncology Group
      • Clinical Trial Overview of Gynecologic Oncology Group
      • European Organization for Research and Treatment of Cancer
      • Clinical Trial Overview of European Organization for Research and Treatment of Cancer
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • The University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
      • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
      • Clinical Trial Overview of Robert H. Lurie Comprehensive Cancer Center of Northwestern University
      • New York University School of Medicine
      • Clinical Trial Overview of New York University School of Medicine
      • UNICANCER Group
      • Clinical Trial Overview of UNICANCER Group
      • Case Comprehensive Cancer Center
      • Clinical Trial Overview of Case Comprehensive Cancer Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Leiomyosarcoma Therapeutics, Global, Clinical Trials by Region, 2014*
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Leiomyosarcoma to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Leiomyosarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Leiomyosarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Leiomyosarcoma to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Leiomyosarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Leiomyosarcoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Leiomyosarcoma Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Leiomyosarcoma Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Leiomyosarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarcoma Alliance for Research through Collaboration, 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Global Services, LLC, 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Nippon Kayaku Co., Ltd., 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Cell Therapeutics, Inc., 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by ArQule, Inc., 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Gynecologic Oncology Group, 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Robert H. Lurie Comprehensive Cancer Center of Northwestern University, 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by UNICANCER Group, 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2014*

List of Figures

  • Leiomyosarcoma Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Leiomyosarcoma to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Leiomyosarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Leiomyosarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Leiomyosarcoma to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Leiomyosarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Leiomyosarcoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Leiomyosarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top